Presentation by Hassan Argomandkhah, Pharmacy LPN Chair (Merseyside), NHS England, at the electronic Transfer of Care to Pharmacy training session on Tuesday 22 January at Formby Hall Golf Resort and Spa
ECO 11: Transfer of Care to Pharmacy - Hassan Argomandkhah, Chair of Pharmacy...Innovation Agency
Hassan introduces the concept and key objectives of transfer of care to pharmacy (TCP). The slides include a project outline, an overview of TCP in Cheshire and Merseyside, and the benefits and potential savings of Electronic Transfer of Care to Pharmacy.
ECO 11: Medicines Optimisation Through Precision - Sir Munir PirmohamedInnovation Agency
Munir Pirmohamed discusses the potential impact of medicines optimisation in terms of ensuring the right patients get the right choice if medicine at the right time. He presents a case history of over prescription and introduces three examples of medicines optimisation through use of genetics, big data, and pharmacogenetics profiling.
How to achieve the NICE guidelines on Managing Medicines in Care HomesKarisBrummitt
The NICE Quality Standard on Managing Medicines in Care Homes is due for publication in March 2015. A NICE Quality Standard is a concise set of statements designed to drive and measure improvements in quality. They are based on national guidelines (including NICE guidelines which consist of around 90 recommendations) and can be used to review services, highlight areas where quality needs to be improved and offer suggestions as to how this can be achieved.
A brief presentation on medicines optimisation and the input a clinical pharmacist can make in improving treatment outcomes for patients and help make evidence led cost effective improvements for the wider NHS.
ECO 11: Transfer of Care to Pharmacy - Hassan Argomandkhah, Chair of Pharmacy...Innovation Agency
Hassan introduces the concept and key objectives of transfer of care to pharmacy (TCP). The slides include a project outline, an overview of TCP in Cheshire and Merseyside, and the benefits and potential savings of Electronic Transfer of Care to Pharmacy.
ECO 11: Medicines Optimisation Through Precision - Sir Munir PirmohamedInnovation Agency
Munir Pirmohamed discusses the potential impact of medicines optimisation in terms of ensuring the right patients get the right choice if medicine at the right time. He presents a case history of over prescription and introduces three examples of medicines optimisation through use of genetics, big data, and pharmacogenetics profiling.
How to achieve the NICE guidelines on Managing Medicines in Care HomesKarisBrummitt
The NICE Quality Standard on Managing Medicines in Care Homes is due for publication in March 2015. A NICE Quality Standard is a concise set of statements designed to drive and measure improvements in quality. They are based on national guidelines (including NICE guidelines which consist of around 90 recommendations) and can be used to review services, highlight areas where quality needs to be improved and offer suggestions as to how this can be achieved.
A brief presentation on medicines optimisation and the input a clinical pharmacist can make in improving treatment outcomes for patients and help make evidence led cost effective improvements for the wider NHS.
How To Boost Hospital Performance By Optimizing Your PharmacyCompleteRx
Assessing and managing productivity is a complex process that takes the rights tools and people. While pharmacy may seem to be a small part of an overall organization, it is actually one of the largest cost centers of a hospital, making it one of the most important departments to optimize and streamline. Learn how your pharmacy’s productivity can impact your hospital’s overall costs, quality, safety and patient satisfaction.
Key Points:
- Analyzing productivity
- Pros and cons of pharmacy productivity management tools
- Use of volume indicators
- Workflows to improve productivity and communication with nursing and hospital staff
Keith Ridge, CBE Chief Pharmaceutical Officer
Presentation from the Winterbourne Medicines Programme Launch held in London on 10 September 2014
Ensuring safe, appropriate and optimised use of medication for people with learning disabilities who demonstrate behaviour that can challenge
3.2 Hubs and collaboration - Greg Kalita, Dave BearmanNHS England
Hubs and collaboration. Hub-based working and collaborating across boundaries to improve access and care. Including examples from Sheffield, Devon and Cornwall. Greg Kalita and Dave Bearman, Northern, Eastern & Western Devon and South Devon & Torbay CCGs.
More than 200 million medication errors occur in NHS per year, now there’s a way to improve dispensing accuracy, reduce administration errors and improve adherence at the same time.
Competing in the Specialty Pharmacy MarketAllison King
URAC President and CEO Kylanne Green presented "Competing in the Specialty Pharmacy Market: Key Competencies for Performance in Value-Based Healthcare" at the at the 2017 Asembia Specialty Pharmacy Summit.
Green reviewed how the growth of specialty drugs, developed to treat patients with chronic or complex genetic diseases and disorders, has attracted a plethora of new players to the specialty pharmacy market, making for fierce competition.
Noting that specialty drugs are expected to account for up to half of all U.S. drug spending by 2020, Green discussed how specialty pharmacists take an active role managing patient care, including by helping patients to cope with treatment side effects, remain adherent to complex medication therapies and obtain resources to help defray drug costs.
Green also discussed how accreditation by a nationally recognized accrediting organization helps pharmacies achieve the clinical, operational and financial best practices that lead to high-quality, low-cost, safe patient care.
Hassan Argomandkhah - Transfers of Care Around MedicineInnovation Agency
Presentation by Hassan Argomandkhah, Pharmacy LPN Chair (Merseyside), NHS England at the Transfers of Care Around Medicine training session on Thursday, 26 September at The Village Hotel, Wirral.
How To Boost Hospital Performance By Optimizing Your PharmacyCompleteRx
Assessing and managing productivity is a complex process that takes the rights tools and people. While pharmacy may seem to be a small part of an overall organization, it is actually one of the largest cost centers of a hospital, making it one of the most important departments to optimize and streamline. Learn how your pharmacy’s productivity can impact your hospital’s overall costs, quality, safety and patient satisfaction.
Key Points:
- Analyzing productivity
- Pros and cons of pharmacy productivity management tools
- Use of volume indicators
- Workflows to improve productivity and communication with nursing and hospital staff
Keith Ridge, CBE Chief Pharmaceutical Officer
Presentation from the Winterbourne Medicines Programme Launch held in London on 10 September 2014
Ensuring safe, appropriate and optimised use of medication for people with learning disabilities who demonstrate behaviour that can challenge
3.2 Hubs and collaboration - Greg Kalita, Dave BearmanNHS England
Hubs and collaboration. Hub-based working and collaborating across boundaries to improve access and care. Including examples from Sheffield, Devon and Cornwall. Greg Kalita and Dave Bearman, Northern, Eastern & Western Devon and South Devon & Torbay CCGs.
More than 200 million medication errors occur in NHS per year, now there’s a way to improve dispensing accuracy, reduce administration errors and improve adherence at the same time.
Competing in the Specialty Pharmacy MarketAllison King
URAC President and CEO Kylanne Green presented "Competing in the Specialty Pharmacy Market: Key Competencies for Performance in Value-Based Healthcare" at the at the 2017 Asembia Specialty Pharmacy Summit.
Green reviewed how the growth of specialty drugs, developed to treat patients with chronic or complex genetic diseases and disorders, has attracted a plethora of new players to the specialty pharmacy market, making for fierce competition.
Noting that specialty drugs are expected to account for up to half of all U.S. drug spending by 2020, Green discussed how specialty pharmacists take an active role managing patient care, including by helping patients to cope with treatment side effects, remain adherent to complex medication therapies and obtain resources to help defray drug costs.
Green also discussed how accreditation by a nationally recognized accrediting organization helps pharmacies achieve the clinical, operational and financial best practices that lead to high-quality, low-cost, safe patient care.
Hassan Argomandkhah - Transfers of Care Around MedicineInnovation Agency
Presentation by Hassan Argomandkhah, Pharmacy LPN Chair (Merseyside), NHS England at the Transfers of Care Around Medicine training session on Thursday, 26 September at The Village Hotel, Wirral.
Testing Telehealth Solutions for Post Acute CareVSee
Telehealth Failures & Secrets to Success Conference 2017 by VSee
Speaker: Tomi Ryba & Margaret Wilmer
Senior Director of Integrated Care of El Camino Hospital
More info at: vsee.com/conference
How to Achieve a PCMH Certification - Small Practice - Practice-centered medi...Donte Murphy
This is a PowerPoint presentation from Dr. Khan, Medical Director, MedPeds Medical Clinic. He has a small practice and is a certified PCMH. In this presentation he shares his strategy that led to his success. This is a powerful presentation for practices of all sizes, whether large or small. For more information, feel free to email us at: marketing@amazingcharts.com.
Newely developed medication order processing system , make it easy to avoid medication error and many drug related problems.
Highly sophisticated computerized system is linked with the medication order processing.
Patient Engagement is growing in importance as consumer expectations of healthcare providers change and as portals and other technologies improve. Early studies show affects on outcomes for patient engagement technologies
Improving Healthcare Quality and Safety while Reducing Costs through Clinical...UCLA CTSI
Apr 6, 2016
Drs. Steven Chen and Michael Hochman, of USC, presented as part of a seminar series on UCLA CTSI Dissemination, Improvement and Implementation Research.
Patient Blood Management: Impact of Quality Data on Patient OutcomesViewics
Patient blood management (PBM) has been proven to improve patient outcomes and save hospitals millions of dollars. Ensuring the quality of your data is central to decision making and critical to having a strong PBM program.
Would you like to learn how your organization can improve patient outcomes by implementing a PBM program based on accurate data?
If so, view this presentation by blood management expert Lance Trewhella. Lance presents how to develop a successful, evidence-based, multidisciplinary PBM program aimed at optimizing the care of patients who might need transfusion.
You’ll learn:
• Current recommendations for blood transfusion utilization
• The impact of quality data on PBM programs
• Best data practices in PBM
Ομιλία – Παρουσίαση: Raymond Anderson, President Commonwealth Pharmaceutical Association and Member of the Pharmacovigilance Risk Assessment Committee (PRAC) at EMA
«Best Practices to inform citizens on Self-medication»
Similar to Hassan Argomandkhah - electronic Transfer of Care to Pharmacy training session (20)
Presentations by Tawfiq Choudhury and Rocco Hadland from the second webinar of the Mastering Cholesterol webinar series on Thursday 11 May 2023, focusing on Statins.
Targeting lipids: a primary and secondary care perspectiveInnovation Agency
Presentations by Dr Sue Kemsley and Dr Gavin Galasko from the first webinar of the Mastering Cholesterol webinar series on Thursday 26 January 2023, focusing on lipid management from a primary and secondary care perspective.
Supporting the optimal detection and management of BP in Primary CareInnovation Agency
Presentation by Jane Briers, Programme Manager - Innovation Agency at the Supporting recovery in Primary Care using Proactive Frameworks for Long Term Conditions event on Thursday 15 September 2022.
Presentation by Dr Lauren Moorcroft, GP Partner - Brookvale Practice at the Supporting recovery in Primary Care using Proactive Frameworks for Long Term Conditions event on Thursday 15 September 2022.
Introduction to Supporting recovery in Primary Care using Proactive Framework...Innovation Agency
Presentation by Julia Reynolds, Associate Director for Transformation - Innovation Agency at the Supporting recovery in Primary Care using Proactive Frameworks for Long Term Conditions event on Thursday 15 September 2022.
Presentation by Paul Brain, Project Manager at the Excel in Health series - Introduction to data webinar on Monday 6 June 2022.
In this session we discussed how SMEs can use data to grow their business and access new opportunities in the market.
Presentations by Mike Kenny, Acting Co-Director of Enterprise and Growth, Innovation Agency and Dr Neil Paul, a GP and Board Member with Cheshire East ICP at the Excel in Health: Understanding the NHS Landscape webinar on Wednesday 11 May 2022.
LCR and Cheshire and Merseyside Health MATTERS networking eventInnovation Agency
Master slide deck from the LCR and Cheshire and Merseyside Health MATTERS networking event on Wednesday 24 November 2021 at Sci-Tech Daresbury Laboratory.
Master slide deck from the Excel in Health webinar series: The NHS landscape presentation.
This webinar identifies the structure of the NHS and its national priorities.
The session will cover the following topics:
Understand the structure of the NHS
Understand the national priorities of the NHS
Recognise the barriers to sale
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
3. Key objectives
Link with with C&M Sustainability and Transformation Plan (STP) objectives.
Reducing emergency bed days and length of stay
Reducing hospital re-admissions*.
Early identification and intervention.
Delivery of care in alternative settings.
Optimise patient care through forging links with community pharmacy.
Improve the health of the C&M population through medicines
optimisation.
Reduced drug waste and impact on 1o
care medicines spend*.
Improved patient satisfaction*
✴ These are the project objectives that would be measured as part of the academic evaluation.
Transfer of Care Around Medicine
4. TCAM/eTCP project team
HA, BP, EC, DB
Partnership arrangements.
-
The NHS Innovation Agency / Academic Health Sciences
Network (AHSN North West Coast).
Liverpool JMU (Academic evaluation).
Transfer of Care Around Medicine
5. Key Features
• Hospital admission notification to
Community pharmacies
• Hospital discharge notification & information
Providing pharmacies with a copy of the relevant
patient discharge information
• eTCP support to provide timely action
Key System Objective
Fully Integrated system to
enable hospitals to transfer
relevant clinical information
between care settings to improve
medicines optimisation
NHS England Funding
To fully develop and implement
software solution in all
Cheshire and Merseyside
NHS Acute Hospital Trusts
Transfer of Care Around Medicine
6. On Patient Admission to Hospital
1. Hospital pharmacy team
assesses risk of meds changes
2. Automated notification
Community Pharmacy
Team
1. Suspend medication
supply
2. Add notes to PMR
3. Await discharge
information
Anonymised monitoring HUB [SAM]
Secure Allocation Management
Monitors eTCP actions
Admission
notification
Warrington trial
Patient selection
✦ Unplanned admission
✦ Polypharmacy
✦ MDS (blister packs)
✦ New event/diagnosis
Transfer of Care Around Medicine
7. On Patient Discharge from Hospital
Automated notification &
transfer of discharge
information
Community Pharmacy
Team
1. Reviews discharge
information
2. Reviews any
outstanding Rx
3. Cancel unwanted Rx
& query new Rx
1. Adds note to clinical
system
2. Post discharge meds
reconciliation
3. Act on any new Rx
query
Discharge
information
Practice
Team
continues to
receive
discharge
information
through
existing
channels
eTCP support to provide timely
action
Patient selection
✦ Unplanned admission
✦ Polypharmacy
✦ MDS (blister packs)
✦ New event/diagnosis
Transfer of Care Around Medicine
8. Patient
admitted to &
discharged
from hospital
Admission notification plus
Discharge notification &
information is sent to the
Community pharmacy
Pathway
TCAM/eTCP support to increase
acceptance and completion rates
electronic Transfer of Care to Pharmacyelectronic Transfer of Care to Pharmacy
9. Enhanced pt.
safety
• Reduced
medication
errors
• Support on
concordance
• Less likelihood
of re-admission
Patients Hospital
Increased
efficiency
• Smoother
discharge
• Reduced 30d
re-admission
• Better links to
primary care
benefits of eTCP - admission & discharge
notifications
Pharmacy
Safer for pts. &
reduces waste
• Access to timely
information
• Better use of
clinical skills
• Less medicines
dispensed and
wasted
GP Practice
Better pt. safety &
reduces waste
• Targets
“revolvingdoor”
pts.
• Identifies pt’s.
medsadherence
issues
• Less medicines
wasted
NHS/CCG/
Social Care
GPs / Commissioners would see a reduction in hospital admissions due to an improvement in medicines adherence.
Community pharmacists have the opportunity to be an integral part of a patient pathway which allows them to utilise
their inherent skills, and to build professional relationships with patients and fellow health professionals.
Key benefits to eTCP partner come from the benefits to their patients
More productivity
• Fewerre-
admissions
• Bettermeds
optimisation
• Lessmedwaste
• Better
managementof
resources
Transfer of Care Around Medicine
14. Hassan Argomandkhah FRPharmS IPresc
Chair of Pharmacy Local Professional Network
NHS England (Merseyside)
hassan.argomandkhah@nhs.net
Transfer of Care Around Medicine